ETFs Holding SNTA »    SNTA Historical Stock Prices »
SNTA News Video: Wed, Oct 21, 2015, 1:34 PM — Wednesday Sector Laggards: Drugs, Hospital & Medical Practitioners

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synta Pharmaceuticals is a biopharmaceutical company focused on research, development and commercialization of oncology medicines for cancer patients. Co.'s lead oncology drug candidate, ganetespib, a heat shock protein 90 (Hsp90) inhibitor, is being evaluated in several large randomized clinical trials including GALAXY-2, a pivotal Phase 3 trial in non-small cell lung cancer, as well as in breast cancer, ovarian cancer and acute myeloid leukemia. Co. is also developing several candidates from its proprietary Hsp90 inhibitor Drug Conjugate program, which utilizes the preferential accumulation of Hsp90 inhibitors in tumors to selectively deliver a range of anti-cancer payloads. Self directed investors in Synta Pharmaceuticals Corp will be interested in keeping up with all Synta Pharmaceuticals Corp news they can find, both SNTA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on SNTA. At RediNews, we simplify this task by presenting both SNTA news releases originating from Synta Pharmaceuticals Corp itself, and SNTA news from a variety of media outlets. Visitors can browse this news online and through our SNTA RSS news feed.


SNTA News — Articles, Videos, & Press Releases

SNTA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

THC News
STE News

RediNews invites you to check out our oh so simple RSS feeds. You don't have to be the webmaster of an investor relations website, integrating investor relations components through an enterprise portal, to work with RSS. Even if you've never worked with a feed for a stock quote for website pages, from a stock market content provider, you can pick up an RSS feed. RSS is not a custom stock feed for website pages, there is nothing custom about it. Rather than custom web content delivered via non-standard XML, our RSS feeds are based on the Really Simple Syndication protocol. To give our feeds a try, look for the RSS icon for any news page (which will look like this): . The feeds can be requested on a symbol by symbol basis, so ideally our news could go on a stock quote page by symbol, or on a broader market page next to a free index chart or index table of the market averages, especially our sector by sector feeds which update intraday on a live basis as new news is added to our database. So whether it is a list of recent news next to an intraday chart, an end of day summary of the markets with all of the most recent news, or a list of the market makers for a given stock, our news can fit in well with the other stock market content your website features.

SNTA News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.